Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Urinary Bladder Neoplasms × Meropenem × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Febrile Neutropenia 2 Urinary Bladder Neoplasms 1 Sepsis 1 Neoplasms 1 Fever 1 Emergencies 1

Interventions

Gemcitabine 6 Cystectomy 5 Cisplatin 4 durvalumab 3 Nivolumab 3 Neoadjuvant Therapy 3 Chemoradiotherapy 3 Anesthesia, Spinal 3 tislelizumab 2 catumaxomab 2 atezolizumab 2 Vitamin E 2 Urinary Diversion 2 Transurethral Resection of Bladder 2 Sunitinib 2 Selenium 2 Robotic Surgical Procedures 2 Multiparametric Magnetic Resonance Imaging 2 Mitomycin 2 Immunohistochemistry 2 Fentanyl 2 Epirubicin 2 Diathermy 2 Cystoscopy 2 Chemoprevention 2 Anesthesia, General 2 valrubicin 1 trifluridine tipiracil drug combination 1 tesetaxel 1 prucalopride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05392634 2022-05-31

MACS

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡